SCHEMBL4428520

SCHEMBL4428520

COCCNS(=O)(=O)Cc1cccc(N)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
HPGD P15428 3/20 0.43
PRMT1 Q99873 1/20 0.43
CYP19A1 P11511 1/20 0.42
POLB P06746 2/20 0.42
LMNA P02545 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
RAB9A P51151 1/20 0.42
CCR2 P41597 6/20 0.41
MEN1 O00255 1/20 0.40
PKM P14618 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 1/20 0.40
ALOX15 P16050 1/20 0.38
HTT P42858 1/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2986910 0.92 ALDH1A1 (0.50) ALDH1A1HPGDPRMT1CYP19A1POLB
SCHEMBL2990886 0.83 CA1 (0.46) ALDH1A1HPGDPRMT1CYP19A1CCR2
SCHEMBL29413066 0.82 PRMT1 (0.44) ALDH1A1HPGDPRMT1CYP19A1LMNA
SCHEMBL8890664 0.81 ALDH1A1 (0.46) ALDH1A1HPGDPOLBLMNASMN1; SMN2
SCHEMBL1998286 0.81 ALDH1A1 (0.60) ALDH1A1HPGDCYP19A1LMNASMN1; SMN2
SCHEMBL15464302 0.80 MAOA (0.41) ALDH1A1PRMT1CYP19A1LMNACCR2
SCHEMBL451865 0.80 PRMT1 (0.46) ALDH1A1PRMT1CYP19A1LMNACCR2
SCHEMBL4428799 0.80 CYP19A1 (0.47) PRMT1CYP19A1LMNACCR2
SCHEMBL1816198 0.79 PRMT1 (0.43) ALDH1A1PRMT1CYP19A1CCR2TSHR
SCHEMBL4428122 0.79 MEN1 (0.54) ALDH1A1CYP19A1POLBLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130338147-A1 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2013-12-19 US disclosed
US-8507498-B2 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2013-08-13 US disclosed
EP-2137166-B1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2012-05-30 EP disclosed
US-20110306602-A1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2011-12-15 US disclosed
EP-2137166-A1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES Ingenium Pharmaceuticals GmbH (DE) 2009-12-30 EP disclosed
WO-2008129080-A1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338147-A1 4,6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES CDK2, CDK6, CDK5 ALDH1A1 3032/4885HPGD 1033/4885PRMT1 1495/4885
US-20110306602-A1 4, 6-DISUBSTITUTED AMINOPYRIMIDINE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES CDK6, CDK2, CDK1 ALDH1A1 2564/4885HPGD 1006/4885PRMT1 1557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.